Pulmonary ultrasound: Diagnostic possibilities for interstitial lung disease associated with rheumatoid arthritis
https://doi.org/10.47360/1995-4484-2023-129-137
Abstract
Interstitial lung disease associated with rheumatoid arthritis (RA-ILD) is one of the systemic manifestations of rheumatoid arthritis (RA) associated with high mortality. According to the latest data, the prevalence of RA-ILD is 3–4%. 26% of patients with RA-ILD develop a progressive interstitial lung disease (ILD) phenotype. To date, for the diagnosis of ILD, including in RA, the ultrasound method of research is being intensively introduced. Ultrasonography of the lungs is a useful adjunct to high-resolution computed tomography (HRCT) and an affordable aid for frequent use. The advantages of lung ultrasound are high information content, reproducibility, ease of use, speed of execution, prognostic value, absence of ionizing radiation. Identification of B-lines in various variants, an uneven, thickened, discontinuous pleural line, and/or delimited cortical consolidations in the form of hypoechoic small areas during ultrasound of the lungs in RA patients can help to promptly suspect ILD and send them to HRCT. The simple and uncomplicated research technology makes it attractive for monitoring the progression of pulmonary fibrosis. The use of ultrasound is necessary, in particular, in the presence of a progressive ILD phenotype, confirmed by HRCT, for conducting serial studies in order to monitor the progression of the disease.
About the Authors
R. R. Ahunova
Kazan State Medical Academy – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
420012, Russian Federation, Kazan, Butlerova str., 36
G. R. Ahunova
Kazan State Medical Academy – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
420012, Russian Federation, Kazan, Butlerova str., 36
References
1. Nasonov EL, Nasonova VA (eds). Rheumatology: National guidelines. Moscow: GEOTAR-Media;2008 (In Russ.).
2. Nasonov EL (ed.). Rheumatology. Russian clinical recommendations. Moscow: GEOTAR-Media;2020 (In Russ.).
3. Balabanova RM, Erdes SF. The incidence and prevalence of rheumatic diseases in Russia in 2012–2013. Nauchno-Prakticheskaya Revmatologia = Rheumato logy Science and Practice. 2015;53(2):120-124 (In Russ.). doi: 10.14412/1995-4484-2015-120-124
4. Chuchalin AG, Avdeev SN, Aisanov ZR, Belevskiy AS, Demura SA, Il’kovich MM, et al. Diagnosis and treatment of idiopathic pulmonary fibrosis. Federal guidelines. Pulmonologiya. 2016;26(4):399-419 (In Russ.). doi: 10.18093/0869-0189-2016-26-4-399-419
5. Olson A, Hartmann N, Patnaik P, Wallace L, Schlenker-Herceg R, Nasser M, et al. Estimation of the prevalence of progressive fibrosing interstitial lung diseases: Systematic literature review and data from a physician survey. Adv Ther. 2021;38(2):854-867. doi: 10.1007/s12325-020-01578-6
6. Koduri G, Norton S, Young S. ERAS (Early Rheumatoid Arthritis Study). Interstitial lung disease has a poor prognosis in rheumatoid arthritis: Results from an inception cohort. Rheumatology (Oxford). 2010;49(8):1483-1489. doi: 10.1093/rheumatology/keq035.
7. Solomon JJ, Fisher A. Connective tissue disease-associated interstitial lung disease: A focused review. J Intensive Care Med. 2015;30(7):392-400. doi: 10.1177/0885066613516579
8. Fotoh DS, Helal A, Rizk MS, Esaily HA. Serum Krebs von den Lungen-6 and lung ultrasound B lines as potential diagnostic and prognostic factors for rheumatoid arthritis associated intersti tial lung disease. Clin Rheumatol. 2021;40(7):2689-2697. doi: 10.1007/s10067-021-05585-y
9. Zhuo J, Zhang Q, Knapp K. OP0035 Examination of interstitial lung disease in patients with rheumatoid arthritis – prevalence time to onset and clinical characteristics. Ann Rheum Dis: 2020 June 2. doi: 10.1136/annrheumdis-2020-eular.1189
10. Wijsenbeek MS, Kreuter M, Fischer A, Mounir B, ZouadLejour L, Wells CD, et al. Non-IPF progressive fibrosing interstitial lung disease (PF-ILD): The patient journey. Am J Respir Crit Care Med. 2018;197:1678.
11. Demoruelle MK, Solomon JJ, Fischer A, Deane KD. The lung may play a role in the pathogenesis of rheumatoid arthritis. Int J Clin Rheumtol. 2014;9(3):295-309. doi: 10.2217/ijr.14.23
12. Fong WWS, Yoong JKC. Interstitial lung disease and rheumatoid arthritis: A review. Proceedings of Singapore Healthcare. 2015;24(1):35-41. doi: 10.1177/201010581502400106
13. Kim EJ, Collard HR, King TE Jr. Rheumatoid arthritis-associated interstitial lung disease: The relevance of histopathologic and radiographic pattern. Chest. 2009;136(5):1397-1405. doi: 10.1378/chest.09-0444
14. Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, et al. Histopathologic pattern and clinical features of rheumatoid arthritisassociated interstitial lung disease. Chest. 2005;127(6):2019-2027. doi: 10.1378/chest.127.6.2019
15. Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-Perez ER, Fischer A, et al. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2016;47(2):588-596. doi: 10.1183/13993003.00357-2015
16. Rohatgi PK. Radiological evaluation of interstitial lung disease. Curr Opin Pulm Med. 2011;17:337-345. doi: 10.1097/MCP.0b013e328347c16a
17. Elicker BM, Kallianos KG, Henry TS. The role of high-resolution computed tomography in the follow-up of diffuse lung disease. Eur Resp Rev. 2017;26(144):170008. doi: 10.1183/16000617.0008-2017
18. Walsh SLF, Devaraj A, Enghelmayer JI, Kishi K, Silva RS, Patel N, et al. Role of imaging in progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180073. doi: 10.1183/16000617.0073-2018
19. Adegunsoye A, Oldham JM, Bellam SK, Montner S, Churpek MM, Noth I, et al. Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases. Ann Am Thorac Soc. 2019;16(5):580-588. doi: 10.1513/AnnalsATS.201807-443OC
20. Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al.; INBUILD Trial Investigators. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381(18):1718-1727. doi: 10.1056/NEJMoa1908681
21. Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, et al. Predicting outcomes in rheumatoid arthritis related interstitial lung disease. Eur Respir J. 2019;53(1):1800869. doi: 10.1183/13993003.00869-2018
22. Yamakawa H, Sato S, Tsumiyama E, Nishizawa T, Kawabe R, Oba T, et al. Predictive factors of mortality in rheumatoid arthritisassociated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria. J Thorac Dis. 2019;11(12):5247-5257. doi: 10.21037/jtd.2019.11.73
23. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al.; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST
24. Assayag D, Elicker BM, Urbania TH, Colby TV, Kang BH, Ryu JH, et al. Rheumatoid arthritis-associated interstitial lung disease: Radiologic identification of usual interstitial pneumonia pattern. Radiology. 2014;270(2):583-588. doi: 10.1148/radiol.13130187
25. Kim EA, Lee KS, Johkoh T, Kim TS, Suh GY, Kwon OJ, et al. Interstitial lung diseases associated with collagen vascular diseases: Radiologic and histopathologic findings. Radiographics. 2002;22 Spec No:S151-S165. doi: 10.1148/radiographics.22.suppl_1.g02oc04s151
26. Laria A, Lurati A, Scarpellini M. Ultrasound in rheumatologic interstitial lung disease: A case report of nonspecific interstitial pneumonia in rheumatoid arthritis. Case Rep Rheumatol. 2015;2015:107275. doi: 10.1155/2015/107275
27. Cogliati C, Antivalle M, Torzillo D, Birocchi S, Norsa A, Bianco R, et al. Standard and pocket-size lung ultrasound devices can detect interstitial lung disease in rheumatoid arthritis patients. Rheumatology (Oxford). 2014;53(8):1497-1503. doi: 10.1093/rheumatology/keu033
28. Moazedi-Fuerst FC, Kielhauser SM, Scheidl S, Tripolt NJ, Lutfi A, Yazdani-Biuki B, et al. Ultrasound screening for interstitial lung disease in rheumatoid arthritis. Clin Exp Rheumatol. 2014;32(2):199-203.
29. Moazedi-Fuerst FC, Kielhauser S, Brickmann K, Tripolt N, Meilinger M, Lufti A, et al. Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus. Clin Exp Rheumatol. 2015;33(4 Suppl 91):S87-S91.
30. Ovsyannikova OB, Ananyeva LP, Korsakova YuO, Koneva OA, Volkov AV, Glukhova SI. Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2013;51(3):279-284 (In Russ.). doi: 10.14412/1995-4484-2013-1502
31. Lichtenstein D, Goldstein I, Mourgeon E, Cluzel P, Grenier P, Rouby JJ. Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome. Anesthesiology. 2004;100(1):9-15. doi: 10.1097/00000542-200401000-00006
32. Lichtenstein DA, Mezière GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: The BLUE protocol. Chest. 2008;134(1):117-125. doi: 10.1378/ chest.07-2800
33. Lichtenstein DA. BLUE-protocol and FALLS-protocol: Two appli cations of lung ultrasound in the critically ill. Chest. 2015;147(6):1659-1670. doi: 10.1378/chest.14-1313
34. Alerhand S, Graumann O, Nelson BP. Physics and basic principles. In: Laursen CB, Rahman NM, Volpicelli G (eds). Thoracic ultrasound. Sheffield:European Respiratory Society;2018:1-13. doi: 10.1183/2312508X.10006017
35. Radzina M, Biederer J. Ultrasonography of the lung. RoFo. 2019;191(10):909-923. doi: 10.1055/a-0881-3179
36. Lee FCY. Lung ultrasound-a primary survey of the acutely dyspneic patient. J Intensive Care. 2016;4(1):57. doi: 10.1186/s40560-016-0180-1
37. Gargani L, Doveri M, D’Errico L. Ultrasound lung comets in systemic sclerosis: A chest sonography hallmark of pulmonary interstitial fibrosis. Rheumatology (Oxford). 2009;48(11):1382-1387. doi: 10.1093/rheumatology/kep263
38. Gutierrez M, Salaffi F, Carotti M. Utility of a simplified ultrasound assessment to assess interstitial pulmonary fibrosis in connective tissue disorders – Preliminary results. Arthritis Res Ther. 2011;13(4):134. doi: 10.1186/ar3446
39. Mohammadi A, Oshnoei S, Ghasemi-rad M. Comparison of a new, modified lung ultrasonography technique with highresolution CT in the diagnosis of the alveolo-interstitial syndrome of systemic scleroderma. Med Ultrason. 2014;16(1):27-31. doi: 10.11152/mu.2014.2066.161.am1so2
40. Gargani L, Volpicelli G. How I do it: Lung ultrasound. Cardiovasc Ultrasound. 2014;12:25. doi: 10.1186/1476-7120-12-25
41. Mitkov VV (ed.). A practical guide to ultrasound diagnostics. General ultrasound diagnostics. Moscow:Vidar-M;2019 (In Russ.).
42. Chuyashenko EV, Zavadovskaya VD, Ageeva TS, Prosekina NM, Perova TB. Ultrasound examination of the lungs with pneumonia. Bulletin of Siberian Medicine. 2017;16(2):47-59 (In Russ.).
43. Safonov DV, Shakhov BE. Ultrasound diagnostics of inflammatory lung diseases. Moscow:Vidar-M;2011 (In Russ.).
44. Mitkov VV, Safonov DV, Mitkova MD, Alekhine MN, Katrich AN, Kabin YuV, et al. RASUDM consensus statement: Lung ultrasound in the context of the COVID-19 (version 2). Ultrasound and Functional Diagnostics. 2020;1:46-77 (In Russ.).
45. Xie HQ, Zhang WW, Sun S. A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: A meta-analysis. Arthritis Res Ther. 2019;21(1):93. doi: 10.1186/s13075-019-1888-9
46. Sperandeo M, Varriale A, Sperandeo G, Filabozzi P, Piattelli ML, Carnevale V, et al. Transthoracic ultrasound in the evaluation of pulmonary fibrosis: Our experience. Ultrasound Med Biol. 2009;35(5):723-729. doi: 10.1016/j.ultrasmedbio.2008.10.009
47. Mena-Vázquez N, Jimenez-Núñez FG, Godoy-Navarrete FJ, Manrique-Arija S, Aguilar-Hurtado MC, Romero-Barco CM, et al. Utility of pulmonary ultrasound to identify interstitial lung disease in patients with rheumatoid arthritis. Clin Rheumatol. 2021;40(6):2377-2385. doi: 10.1007/s10067-021-05655-1
Review
For citations:
Ahunova R.R., Ahunova G.R. Pulmonary ultrasound: Diagnostic possibilities for interstitial lung disease associated with rheumatoid arthritis. Rheumatology Science and Practice. 2023;61(1):129-137. (In Russ.) https://doi.org/10.47360/1995-4484-2023-129-137
Views:
377
Email this article 